MONTELEONE, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 77.730
AS - Asia 8.935
EU - Europa 6.493
SA - Sud America 1.438
AF - Africa 133
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 21
Totale 94.771
Nazione #
US - Stati Uniti d'America 77.493
SG - Singapore 4.965
CN - Cina 1.672
BR - Brasile 1.230
HK - Hong Kong 1.096
IT - Italia 1.073
DE - Germania 1.007
UA - Ucraina 942
IE - Irlanda 841
RU - Federazione Russa 525
GB - Regno Unito 487
VN - Vietnam 347
SE - Svezia 336
FR - Francia 324
FI - Finlandia 297
PL - Polonia 277
KR - Corea 248
CA - Canada 124
IN - India 105
ID - Indonesia 82
AR - Argentina 81
MX - Messico 77
NL - Olanda 72
BD - Bangladesh 71
JP - Giappone 69
AT - Austria 65
BE - Belgio 65
ZA - Sudafrica 51
TR - Turchia 46
IQ - Iraq 44
ES - Italia 41
EC - Ecuador 30
LT - Lituania 24
CL - Cile 22
PK - Pakistan 22
PY - Paraguay 20
CH - Svizzera 19
AU - Australia 18
TN - Tunisia 18
CO - Colombia 17
MA - Marocco 17
VE - Venezuela 17
CZ - Repubblica Ceca 16
IR - Iran 16
RO - Romania 16
IL - Israele 15
AE - Emirati Arabi Uniti 13
EU - Europa 13
PH - Filippine 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
EG - Egitto 11
KZ - Kazakistan 11
GR - Grecia 10
KE - Kenya 10
KG - Kirghizistan 10
AZ - Azerbaigian 9
NO - Norvegia 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
PE - Perù 8
JO - Giordania 7
SC - Seychelles 7
BG - Bulgaria 6
HN - Honduras 6
LK - Sri Lanka 6
MK - Macedonia 6
TH - Thailandia 6
UY - Uruguay 6
LB - Libano 5
MY - Malesia 5
SK - Slovacchia (Repubblica Slovacca) 5
A1 - Anonimo 4
AL - Albania 4
CR - Costa Rica 4
DK - Danimarca 4
DM - Dominica 4
GY - Guiana 4
HU - Ungheria 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
JM - Giamaica 3
KW - Kuwait 3
RS - Serbia 3
AM - Armenia 2
BO - Bolivia 2
ET - Etiopia 2
GA - Gabon 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 94.747
Città #
Woodbridge 21.802
Wilmington 19.157
Houston 18.452
Fairfield 2.659
Singapore 2.047
Ann Arbor 2.041
Ashburn 1.562
Chandler 1.334
Hong Kong 1.084
Seattle 1.067
Cambridge 885
Jacksonville 834
Beijing 784
Dublin 753
Medford 603
Dearborn 468
Rome 436
Santa Clara 410
The Dalles 319
New York 292
Lawrence 278
Los Angeles 271
Kraków 221
Buffalo 162
Council Bluffs 162
Zhengzhou 155
San Diego 153
Dallas 129
Menlo Park 125
Ho Chi Minh City 118
São Paulo 116
Chicago 97
Mülheim 97
London 95
Moscow 94
Milan 91
Hanoi 82
Munich 74
Nuremberg 74
Helsinki 67
Redondo Beach 67
Boardman 65
Brussels 62
Redwood City 60
Jakarta 58
Mountain View 55
Seoul 54
Rio de Janeiro 53
Warsaw 50
Shanghai 48
Montreal 46
Norwalk 44
Tokyo 42
Brooklyn 41
San Mateo 41
Denver 40
Columbus 39
Toronto 35
University Park 35
Vienna 35
Chennai 34
Colorado Springs 34
Johannesburg 34
Orem 34
Palo Alto 33
Verona 33
Belo Horizonte 32
Phoenix 32
Falls Church 31
San Francisco 30
Atlanta 29
Indianapolis 29
Lappeenranta 29
Guangzhou 28
Hefei 28
Hangzhou 27
Poplar 27
Stockholm 25
Kunming 24
Nanjing 24
Boston 23
Frankfurt am Main 23
San Jose 22
Mexico City 21
Curitiba 20
Dhaka 19
Saint Petersburg 19
Baghdad 18
Brasília 18
Del Norte 18
Detroit 18
Manchester 18
Naples 18
Redmond 18
Salt Lake City 18
Jinan 17
Kilburn 17
North Hollywood 17
Wuhan 17
Da Nang 16
Totale 81.592
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 599
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 588
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 546
Appropriate nutrient supplementation in celiac disease 539
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 534
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 533
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 526
A functional role for Smad7 in sustaining colon cancer cell growth and survival 495
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 490
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 484
Interleukin-34 sustains inflammatory pathways in the gut 484
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 484
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 483
Role of interleukin-21 in inflammation and allergy 481
Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells 478
Characterization of IL-17A-producing cells in celiac disease mucosa 476
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 472
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 471
No change in the mucosal gut microbiome is associated with celiac disease-specific microbiome alteration in adult patients 471
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 470
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 464
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 462
Regulation of gut inflammation and Th17 cell response by interleukin-21 461
IL-21 comes of age as a regulator of effector T cells in the gut 460
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 460
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 459
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 458
The dual role of Smad7 in the control of cancer growth and metastasis 458
Aryl hydrocarbon receptor and colitis 456
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 454
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 454
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 453
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 452
The gut-skin axis in health and disease: A paradigm with therapeutic implications 452
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 451
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 450
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 448
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease 448
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 447
Activated STAT4 and a functional role for IL-12 in human Peyer's patches 447
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 447
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 446
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 446
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 445
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 445
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 444
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 443
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 442
null 442
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy 441
Tofacitinib for the treatment of ulcerative colitis 441
An overview of the role of innate lymphoid cells in gut infections and inflammation 440
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 440
Bacteria and mucosal immunity 439
Targeting interleukin-21 in immune-mediated pathologies 439
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 439
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 439
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 438
Autocrine regulation of IL-21 production in human T lymphocytes 437
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 437
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 437
Immunity, inflammation, and allergy in the gut 436
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 435
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 435
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease 434
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 434
Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 433
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 433
Colorectal cancer chemoprevention by mesalazine and its derivatives 432
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 431
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 430
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 430
Interleukin-21 (IL-21) controls inflammatory pathways in the gut 428
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 427
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 427
IL-21 in the pathogenesis and treatment of skin diseases 426
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 424
Collagen matrix injection combined with flap repair for complex anal fistula 424
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 424
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 423
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 423
New players in the cytokine orchestra of inflammatory bowel disease 422
IL-21 regulates experimental colitis by modulating the balance between T-reg and Th17 cells 421
TGF-beta 1 and Smad7 in the regulation of IBD 420
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 420
Defective expression of scavenger receptors in celiac disease mucosa 420
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 420
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 419
Antisense approach to inflammatory bowel disease: Prospects and challenges 419
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 418
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures 418
Role of Smad7 in inflammatory bowel diseases 417
The dual role of inflammation in colon carcinogenesis 417
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts T-reg cells via regulation of MIP-3 alpha 415
Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease 414
Emerging immunological targets in inflammatory bowel disease 414
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 413
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism 412
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 412
T-cell-directed therapies in inflammatory bowel diseases 411
Totale 44.976
Categoria #
all - tutte 231.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.032 0 0 0 0 0 1.536 1.679 1.338 313 473 476 217
2021/20222.997 149 243 125 168 81 262 136 117 383 294 223 816
2022/20233.585 360 306 68 451 334 819 299 234 333 85 204 92
2023/20241.305 164 45 88 48 130 265 77 217 19 19 33 200
2024/20258.900 233 1.706 963 547 205 790 549 378 846 725 1.153 805
2025/20266.089 1.077 648 1.478 1.195 1.330 361 0 0 0 0 0 0
Totale 95.965